Plant phenolics inhibit neutrophil elastase

Planta Medica

Volumn 72, Issue 12, 2006, Pages 1127-1131

  Hrenn, Andrea ^a   Steinbrecher, Thomas ^a   Labahn, Andreas ^a   Schwager, Joseph ^b   Schempp, Christoph M ^a   Merfort, Irmgard ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b DSM NUTRITIONAL PRODUCTS LTD   (Switzerland)

Author keywords

Agrimoniin; Genistein; Human neutrophil elastase; Ligand docking; Phenolics; Proliferation; Resveratrol; Tannins

Indexed keywords

ADENOSINE TRIPHOSPHATE; AGRIMONIIN; ELLAGITANNIN; GENISTEIN; LEUKOCYTE ELASTASE; LEUKOCYTE ELASTASE INHIBITOR; PEDUNCULAGIN; PHENOL DERIVATIVE; PLANT EXTRACT; SERINE PROTEINASE; TANNIN; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ASSAY; IC 50; NONHUMAN;

CATECHIN; GENISTEIN; HUMANS; HYDROLYZABLE TANNINS; LEUKOCYTE ELASTASE; PHENOLS; PHENYLETHYL ALCOHOL; PLANT EXTRACTS; PROTEINASE INHIBITORY PROTEINS, SECRETORY; STILBENES;

EID: 33750394966     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-946700     Document Type: Article

References (28)

1. Wiedow O, Wiese F, Christophers E. Lesional elastase activity in psoriasis - Diagnostic and prognostic-significance. Arch Dermat Res 1995; 287: 632-5
2. Ohbayashi H. Current synthetic inhibitors of human neutrophil elastase. Exp Opin Invest Drugs 2002; 12: 65-84
3. Meyer-Hoffert U, Wingertszahn J, Wiedow O. Human leukocyte elastase induces keratinocyte proliferation by epidermal growth factor receptor activation. J Investig Dermatol 2004; 123: 338-45
4. Wiedow O, Meyer-Hoffert U. Neutrophil serine proteases: potential key regulators of cell signalling during inflammation. J Int Med 2005; 257:319-28
5. Bos MA, Vennat B, Meunier MT, Pouget MP, Pourrat A, Fialip J. Procyanidins from tormentil: Antioxidant properties towards lipoperoxidation and anti-elastase activity. Biol Pharm Bull 1996; 19: 146-8
6. Shimizu M, Deguchi A, Joe AK, McKoy JF, Moriwaki H, Weinstein IB. EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells. J Exp Ther Oncol 2005; 5: 69-78
7. Siedle B, Murillo R, Hucke O, Labahn A, Merfort I. Structure activity relationship studies of cinnamic acid derivatives as inhibitors of human neutrophil elastase revealed by ligand docking calculations. Pharmazie 2003; 58: 337-9
8. Geiss F, Heinrich M, Hunkler D, Rimpler H. Proanthocyanidins with (+)-epicatechin units from Byrsonima crassifolia bark. Phytochemistry 1995; 39: 635-43
9. Geiger C, Rimpler H. Ellagitannins from Tormentillae rhizoma and Alchemillae herba. Planta Med 1990; 56: 585-6
10. Schorr K, Rott A, Da Costa FB, Merfort I. Optimisation of a human neutrophil elastase assay and investigation of the effect of sesquiterpene lactones. Biologicals 2005; 33: 175-84
11. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988; 106: 761-71
12. Kramer B, Rarey M, Lengauer T. Evaluation of the FlexX incremental construction algorithm for protein-ligand dockings. Proteins 1999; 37: 228-41
13. Rarey M, Kramer B, Lengauer T, Klebe G. A fast flexible docking method using an incremental construction algorithm. J Mol Biol 1996; 261: 470-89
14. Navia MA, McKeever BM, Springer JP, Lin TY, Williams HR, Fluder EM et al. Structure of human neutrophil elastase in complex with a peptide chloromethyl ketone inhibitor at 1.84-Å resolution. Proc Natl Acad Sci USA 1989; 86: 7-11
15. Vriend G. WHAT IF: a molecular modeling and drug design program. J Mol Graph 1990; 8: 52-6
16. Siedle B, Cisielski S, Murillo R, Löser B, Castro V, Klaas CA et al. Sesquiterpene lactones as inhibitors of human neutrophil elastase. Bioorg Med Chem 2002; 10: 2855-61
17. Scholz E. Pflanzliche Gerbstoffe. Dtsch Apoth Ztg 1994; 134: 17-29
18. Sartor L, Pezzato E, Dell'Aica I, Caniato R, Biggin S, Garbisa S. Inhibition of matrix-proteases by polyphenols: chemical insights for anti-inflammatory and anti-invasion drug design. Biochem Pharmacol 2002; 64: 229-37
19. Rotondo S, Rajtar G, Manarini S, Celardo A, Rotilio D, de Gaetano G et al. Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function. Brit J Pharmacol 1998; 123: 1691-9
20. Tou JS. Differential regulation of phosphatidic acid (PA) formation and degranulation by polyphenolic antioxidants in stimulated human neutrophils. Faseb J 2002; 16: A538-9
21. Tuluc F, Garcia A, Bredetean O, Meshki J, Kunapuli SP. Primary granule release from human neutrophils is potentiated by soluble fibrinogen through a mechanism depending on multiple intracellular signaling pathways. Am J Physiol Cell Physiol 2004; 287: C1264-72
22. Melzig MF, Löser B, Cisielski S. Inhibition of neutrophil elastase activity by phenolic compounds from plants. Pharmazie 2001; 56: 967-70
23. Melzig MF, Löser B, Lobitz GO, Tamayo-Castillo G, Merfort I. Inhibition of granulocyte elastase activity by caffeic acid derivatives. Pharmazie 1999; 54: 712
24. Steinbrecher T, Case DA, Labahn A. A multistep approach to structure-based drug design: studying ligand binding at the human neutrophil elastase. J Med Chem 2006; 49: 1837-44
25. Shen GX, Jeong WS, Hu R, Kong ANT. Regulation of Nrf2, NF-kappaB, and AP-1 signaling pathways by chemopreventive agents. Antioxid Redox Signal 2005; 7: 1648-63
26. Sottong PR, Rosebrock JA, Britz JA, Kramer TR. Measurement of T-lymphocyte responses in whole-blood cultures using newly synthesized DNA and ATP. Clin Diagn Lab Immunol 2000; 7: 307-11
27. Crouch SPM, Kozlowski R, Slater KJ, Fletcher J. The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. J Immunol Methods 1993; 160: 81-8
28. Dvorakova K, Dorr RT, Valcic S, Timmermann B, Alberts DS. Pharmacokinetics of the green tea derivative, EGCG, by the topical route of administration in mouse and human skin. Cancer Chemother Pharmacol 1999; 43: 331-5